医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2013年
9期
1743-1745
,共3页
黄修海%刘祥%毕超%陈仕武
黃脩海%劉祥%畢超%陳仕武
황수해%류상%필초%진사무
肝肾综合征/药物疗法%奥曲肽/治疗应用
肝腎綜閤徵/藥物療法%奧麯肽/治療應用
간신종합정/약물요법%오곡태/치료응용
Hepatorenal Syndrome/DT%Octreotide/TU
[目的]探讨奥曲肽治疗肝肾综合征(HRS)的临床疗效。[方法]将48例 HRS 患者随机分为两组,对照组23例,给予白蛋白和呋塞米及其他护肝等综合治疗,治疗组25例,在对照组基础上给予奥曲肽治疗,比较两组患者的疗效及治疗前后血肌酐、尿素氮、24h 尿量、门静脉及脾静脉内径、血流动力学的变化。[结果]治疗组总有效率80%显著高于对照组43.5%(P <0.05);治疗组血肌酐、尿素氮水平较对照组显著降低,尿量较对照组显著增加,门静脉及脾静脉内径较治疗前明显缩小,其差异均有统计学意义(均 P <0.05),血流动力学两组比较无显著性差异(P >0.05)。[结论]在白蛋白、呋塞米及护肝治疗的基础上加用奥曲肽治疗 HRS 可降低患者血肌酐、尿素氮水平,增加尿量,减小门静脉压力且对血流动力学无影响,是一种简单、有效的治疗方法。
[目的]探討奧麯肽治療肝腎綜閤徵(HRS)的臨床療效。[方法]將48例 HRS 患者隨機分為兩組,對照組23例,給予白蛋白和呋塞米及其他護肝等綜閤治療,治療組25例,在對照組基礎上給予奧麯肽治療,比較兩組患者的療效及治療前後血肌酐、尿素氮、24h 尿量、門靜脈及脾靜脈內徑、血流動力學的變化。[結果]治療組總有效率80%顯著高于對照組43.5%(P <0.05);治療組血肌酐、尿素氮水平較對照組顯著降低,尿量較對照組顯著增加,門靜脈及脾靜脈內徑較治療前明顯縮小,其差異均有統計學意義(均 P <0.05),血流動力學兩組比較無顯著性差異(P >0.05)。[結論]在白蛋白、呋塞米及護肝治療的基礎上加用奧麯肽治療 HRS 可降低患者血肌酐、尿素氮水平,增加尿量,減小門靜脈壓力且對血流動力學無影響,是一種簡單、有效的治療方法。
[목적]탐토오곡태치료간신종합정(HRS)적림상료효。[방법]장48례 HRS 환자수궤분위량조,대조조23례,급여백단백화부새미급기타호간등종합치료,치료조25례,재대조조기출상급여오곡태치료,비교량조환자적료효급치료전후혈기항、뇨소담、24h 뇨량、문정맥급비정맥내경、혈류동역학적변화。[결과]치료조총유효솔80%현저고우대조조43.5%(P <0.05);치료조혈기항、뇨소담수평교대조조현저강저,뇨량교대조조현저증가,문정맥급비정맥내경교치료전명현축소,기차이균유통계학의의(균 P <0.05),혈류동역학량조비교무현저성차이(P >0.05)。[결론]재백단백、부새미급호간치료적기출상가용오곡태치료 HRS 가강저환자혈기항、뇨소담수평,증가뇨량,감소문정맥압력차대혈류동역학무영향,시일충간단、유효적치료방법。
[Objective]To explore the clinical efficacy of octreotide for the treatment of hepatorenal syn-drome(HRS).[Methods]A total of 48 patients with HRS were randomly divided into two groups.The con-trol group(n = 23)was given combination therapy including albumin,furosemide and other liver protection drugs.The treatment group(n =25)was given octreotide based on the treatment of control group.The effica-cy,serum creatinine(Cr),urea nitrogen(BUN),24h urine volume,diameter of portal and splenic vein and he-modynamic changes before and after treatment were compared between two groups.[Results]The total effec-tive rate of treatment group was 80%,which was markedly higher than that in control group(43.5%)(P <0.05).Compared with control group,serum Cr and BUN in treatment group decreased markedly,while urine volume increased markedly.Compared with before treatment,the diameter of portal veins and splenic veins obviously decreased after treatment,and there was significant difference(P <0.05).There was no significant difference in hemodynamics between two groups(P >0.05).[Conclusion]Based on the treatment with albu-min,furosemide and liver protection drug,octreotide for the treatment of HRS can reduce the level of serum Cr and BUN,increase urine volume,decrease portal vein pressure,and has no influence on hemodynamics. Therefore,it is a simple and effective treatment method.